Clinical Trial

Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1

Completed
View on ClinicalTrials.gov →
Summary
This study is stage 2, round 1 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
Protocol Amendment History 4 changes
critical Trial completed 2026-06-02
notable Enrollment reduced: 300 -> 267 participants 2026-06-02
notable Primary completion moved earlier: 2027-06 -> 2026-05-07 2026-06-02
minor Completion moved earlier: 2027-06 -> 2026-05-07 2026-06-02
Trial Details
NCT Number NCT07549126
Lead Sponsor Yale University
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Opioid Use Disorder, Clinical Decision Support
Enrollment 267 participants
Start Date 2026-04-02
Primary Completion 2026-05-07 (estimated)
Study Completion 2026-05-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-30